Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
3.816 EUR | +2.86% | +2.47% | -19.15% |
Apr. 11 | Valneva: Deep Track Biotechnology Master holds less than 5% of the capital | CF |
Mar. 26 | Valneva Kicks Off Early-stage Trial for Zika Vaccine Candidate | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.15% | 548M | |
-0.02% | 42.11B | |
+49.00% | 40.08B | |
+5.04% | 40B | |
-11.32% | 26.87B | |
+5.25% | 24.58B | |
-23.83% | 18.44B | |
-1.62% | 11.94B | |
+22.75% | 11.66B | |
+6.44% | 11.01B |
- Stock Market
- Equities
- VLA Stock
- News Valneva
- Valneva Prices Upsized Global Offering of $99.9 Million of Ordinary Shares and ADSs